These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8799749)

  • 1. Issues of biocompatibility: heparin-coated extracorporeal circuit.
    Hsu LC
    Int Anesthesiol Clin; 1996; 34(2):109-22. PubMed ID: 8799749
    [No Abstract]   [Full Text] [Related]  

  • 2. Biocompatibility of heparin-coated extracorporeal bypass circuits: a randomized, masked clinical trial.
    Muehrcke DD; McCarthy PM; Kottke-Marchant K; Harasaki H; Pierre-Yared J; Borsh JA; Ogella DA; Cosgrove DM
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):472-83. PubMed ID: 8751516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospects for clinical applications of polymer-coated haemoconcentrator on extracorporeal circuit in cardiopulmonary bypass surgeries.
    Tagaya M; Takahashi S; Matsuda M; Takasaki T; Hamaishi M; Hara K
    Int J Artif Organs; 2016 Oct; 39(8):415-420. PubMed ID: 27646632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin-coated cardiopulmonary bypass circuits.
    Gravlee GP
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):213-22. PubMed ID: 8204814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-coated circuits reduce the formation of TNF alpha during cardiopulmonary bypass.
    Yamada H; Kudoh I; Hirose Y; Toyoshima M; Abe H; Kurahashi K
    Acta Anaesthesiol Scand; 1996 Mar; 40(3):311-7. PubMed ID: 8721461
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biocompatibility reflected by haemostasis variables during cardiopulmonary bypass using heparin-coated circuits.
    Borowiec J; Bagge L; Saldeen T; Thelin S
    Thorac Cardiovasc Surg; 1997 Aug; 45(4):163-7. PubMed ID: 9323816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits.
    Gunaydin S; Mccusker K; Vijay V
    J Extra Corpor Technol; 2005 Sep; 37(3):290-5. PubMed ID: 16350383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST; Videm V; Pedersen T; Karlsen H; Mollnes TE; Brosstad F; Svennevig JL
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of biocompatibility between the open circuit and closed circuit in cardiopulmonary bypass.
    Nishida H; Aomi S; Tomizawa Y; Endo M; Koyanagi H; Nojiri C; Oshiyama H; Kido T; Yokoyama K
    Artif Organs; 1999 Jun; 23(6):547-51. PubMed ID: 10392283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro.
    Hammarén E; Rosenberg PH; Hynynen M
    Br J Anaesth; 1999 Jan; 82(1):38-40. PubMed ID: 10325833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The benefit of heparin-bound circuits.
    Moulijn AC; Amsel BJ
    J Thorac Cardiovasc Surg; 1996 Aug; 112(2):557-8. PubMed ID: 8751535
    [No Abstract]   [Full Text] [Related]  

  • 12. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anticoagulation.
    Kuitunen AH; Heikkilä LJ; Salmenperä MT
    Ann Thorac Surg; 1997 Feb; 63(2):438-44. PubMed ID: 9033316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of silicone-coated oxygenator in cardiopulmonary bypass.
    Shimamoto A; Kanemitsu S; Fujinaga K; Takao M; Onoda K; Shimono T; Tanaka K; Shimpo H; Yada I
    Ann Thorac Surg; 2000 Jan; 69(1):115-20. PubMed ID: 10654498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal circulation, hemocompatibility, and biomaterials.
    Janvier G; Baquey C; Roth C; Benillan N; Bélisle S; Hardy JF
    Ann Thorac Surg; 1996 Dec; 62(6):1926-34. PubMed ID: 8957436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biocompatibility in cardiopulmonary bypass.
    Hsu LC
    J Cardiothorac Vasc Anesth; 1997 May; 11(3):376-82. PubMed ID: 9161907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined use of aprotinin and a heparin-bonded cardiopulmonary bypass system for aortic aneurysm repair.
    Gallagher JM; Brown ME; Gasior TA
    J Cardiothorac Vasc Anesth; 1995 Dec; 9(6):728-30. PubMed ID: 8664469
    [No Abstract]   [Full Text] [Related]  

  • 18. A new heparin-bonded dense membrane lung combined with minimal systemic heparinization prolonged extracorporeal lung assist in goats.
    Okamoto T; Tashiro M; Sakanashi Y; Tanimoto H; Imaizumi T; Sugita M; Terasaki H
    Artif Organs; 1998 Oct; 22(10):864-72. PubMed ID: 9790085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
    Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
    Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
    Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
    J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.